MDA Space Ltd. MDA ← Back to all reports

MDA Space Ltd.

MDA · Industrials
A ★★★★ Buy
Aug 19, 2026 · Score 93 · Type B — Growth-style analysis Used for higher-growth companies — weighs revenue trajectory, total addressable market (TAM) expansion, and forward-looking multiples. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $35.26
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $34.00 ($32.00–$36.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $44.80
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+27.1%

Type B - MDA Space Ltd. (MDA) 20260819 Stock Analysis

📅 MDA Key Upcoming Events

🏢 Step 1: MDA Company Overview & Business Model

Q1-A1. What is MDA?

Q1-A2. How Does MDA Make Money?

Q1-A3. MDA’s Revenue Segments & Core Income Sources

Q1-A4. Who Are MDA’s Competitors?

Q1-A5. What Problem Does MDA Solve?

Q1-A6. MDA Key Milestones: Past 12 Months

Q1-A7. Step 1 Key Takeaways

🌲 Step 2: MDA’s Economic Moat, Market Size & Scalability

Q2-A1. Does MDA Have a Durable Economic Moat?

Q2-A2. How Big Is MDA’s Market? (TAM)

Q2-A3. How Real Is MDA’s TAM? (Quality Check)

Q2-A4. Can MDA Keep Expanding Its Market?

Q2-A5. Step 2 Key Takeaways

🚀 Step 3: How Fast Is MDA Growing? Hyper-Growth Metrics

Q3-A1. How Fast Is MDA Growing? (Revenue Trajectory)

Q3-A2. MDA’s Key Growth Metrics

Q3-A3. Are MDA’s Unit Economics Improving?

Q3-A4. Step 3 Key Takeaways

💪 Step 4: MDA’s Profit Potential & Free Cash Flow

Q4-A1. Can MDA Turn Growth Into Profit?

Q4-A2. Does MDA Generate Free Cash Flow?

Q4-A3. Step 4 Key Takeaways

👔 Step 5: MDA Management & Shareholder Alignment

Q5-A1. Who Leads MDA? (Founder & Management)

Q5-A2. Is MDA’s Management Aligned With Shareholders?

Q5-A3. Step 5 Key Takeaways

⛵ Step 6: MDA Market Flow & Sentiment

Q6-A1. Analyst Consensus vs MDA Guidance

Q6-A2. What Is MDA’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🧨 Step 7: MDA Catalysts & Price Triggers

Q7-A1. What Could Re-Rate MDA Stock? (Next 12 Months)

Q7-A2. MDA’s Estimate Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is MDA Fairly Valued? Valuation Analysis

Q8-A1. MDA’s Key Valuation Multiples

Q8-A2. MDA vs Peers: Valuation Comparison

Q8-A3. What Is MDA Worth in the Future? (Forward Valuation)

Q8-A3-1. What Growth Hurdle Does the Market Demand From MDA? (Forward Valuation Alternative)

Q8-A4. Final Valuation Adjustment

Q8-A5. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of MDA? Fatal Risks & Pre-Mortem

Q9-A1. Is MDA Burning Cash & Diluting Shareholders?

Q9-A2. Do Competition or Regulation Threaten MDA?

Q9-A3. MDA Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: MDA Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy MDA? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. MDA’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is MDA’s Heavy Reliance on the Telesat Lightspeed Program Its Biggest Weakness?

Q2: Can MDA’s 25.9x Forward P/E Be Justified by the Space Infrastructure Supercycle?

Q3: Will the Integration of Blue Canyon Technologies Disrupt MDA’s Margins?

Q4: How Does the CLS Acquisition Alter MDA’s Software and Recurring Revenue Profile?

Q5: Can MDA Defend Its Monopoly in Lunar and Orbital Robotics Against Emerging US Competitors?

Q6: Will Canada’s Sovereign Defense Space Investments Create a Reliable Domestic Floor for MDA?

Q7: How Does the Continued Use of Bought-Deal Equity Offerings Impact Shareholder Returns?

Q8: Can the CHORUS Earth Observation Constellation Steal Market Share from Legacy Providers?

Q9: Are Recent Insider Sales by Management a Red Flag for Near-Term Operations?

Q10: Does the NYSE Dual Listing Successfully Bridge the Valuation Gap With US Peers?